AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,398.00p
   
  • Change Today:
      12.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.64m
  • Volume: 1,615,453
  • Market Cap: £161,235m
  • RiskGrade: 123
  • Beta: 0.01

Latest Deals

Traded Action Notifier PriceAmountValue
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07
06-Mar-25 Transfer From Pascal Soriot 0.000p 89,962 £0.00
05-Mar-25 Buy Dividends Aradhana Sarin 0.000p 28 £0.00
05-Mar-25 Buy Dividends Pascal Soriot 0.000p 248 £0.00
04-Mar-25 Transfer From Aradhana Sarin 0.000p 2,021 £0.00
04-Mar-25 Transfer From Pascal Soriot 0.000p 17,357 £0.00
19-Nov-24 Buy Tony Mok 12,679.63p 1,500 £190,194.50
15-Nov-24 Buy Michel Demare 10,030.35p 2,000 £200,607.04
14-Nov-24 Buy Pascal Soriot 10,203.00p 20,000 £2,040,599.98
11-Nov-24 Buy Philip A J Broadley 10,169.91p 980 £99,665.11
13-Sep-24 Buy Michel Demare 117.93p 2,000 £2,358.55
10-Jun-24 Transfer To Pascal Soriot 0.000p 297,418 £0.00

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,398.00p
Change Today 12.00p
% Change 0.12 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 1,615,453
Shares Issued 1,550.64m
Market Cap £161,235m
Beta 0.01
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.18% below the market average93.18% below the market average93.18% below the market average93.18% below the market average93.18% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
26.08% below the market average26.08% below the market average26.08% below the market average26.08% below the market average26.08% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Income
60.33% below the market average60.33% below the market average60.33% below the market average60.33% below the market average60.33% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.52% above the market average86.52% above the market average86.52% above the market average86.52% above the market average86.52% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 29-May-2025

Time Volume / Share Price
15:14 0 @ 10,464.00p
15:14 0 @ 10,464.00p
15:12 1 @ 10,460.00p
15:07 0 @ 10,460.00p
15:12 0 @ 10,464.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page